A method demonstrates organogenesis in breast tissue using human stem cells, suggesting enhanced cellular diversity and development.
Current breast organoid models, primarily based on self-assembly, face limitations in accurately mimicking the complex stages of tissue development, notably in replicating detailed tissue architectures and cellular diversity. Here, we demonstrate that a solitary human breast stem cell can, within a controlled hydrogel extracellular matrix environment, autonomously generate niche signals that drive directed organogenesis, producing organoids with mesenchymal and parenchymal components. This system surpasses traditional models by forming complex, heterogeneous ductal-lobular structures akin to those in native human breast tissue with the emergence of mesenchyme-like stroma. Utilizing long-term, high-resolution live imaging, we quantitatively analyze the dynamic tissue development and morphogenesis, capturing cellular behaviors crucial for understanding both development and disease. The inclusion of patient-derived cells from diverse biological backgrounds, including pre- and post-menopausal donors, significantly enhances the model's applicability. Our findings underscore that this controlled organogenesis approach represents a major leap over existing methods, offering a robust platform for probing the intricacies of human breast tissue development and its responses to environmental cues
No takes yet. Share an insight, caveat, or question.
Rauner et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: